PUBLISHER: The Business Research Company | PRODUCT CODE: 1994628
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994628
Human acellular dermis refers to a biological scaffold derived from donated human skin in which all living cells are removed, leaving behind a collagen-rich extracellular matrix that supports tissue regeneration and integration. It is widely used in reconstructive and regenerative medicine to promote natural healing, reduce immune rejection, and provide structural support for soft tissue repair and wound healing.
The key product types of human acellular dermis include recombinant acellular dermis, lyophilized acellular dermis, decellularized acellular dermis, and fresh acellular dermis. Recombinant acellular dermis refers to dermal products engineered using recombinant techniques to provide a scaffold for tissue regeneration and wound healing. These products are available in structural forms such as sheet-type acellular dermis, mesh-type acellular dermis, and gel-type acellular dermis. Distribution channels include direct sales, distributors, and online retail platforms. Applications cover burn treatment, soft tissue reconstruction, wound management, plastic surgery, and orthopedic surgery, with end users including hospitals, ambulatory surgical centers, specialty clinics, and research institutions.
Tariffs are impacting the human acellular dermis market by increasing costs of imported processing equipment, sterilization systems, preservation materials, and cold-chain logistics used in dermal graft production. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported biomaterials, while Asia-Pacific faces cost pressure on processed tissue exports. These tariffs are increasing product pricing and procurement timelines. However, they are also encouraging domestic tissue processing facilities, regional donor tissue utilization, and investment in local regenerative medicine manufacturing capabilities.
The human acellular dermis market research report is one of a series of new reports from The Business Research Company that provides human acellular dermis market statistics, including human acellular dermis industry global market size, regional shares, competitors with a human acellular dermis market share, detailed human acellular dermis market segments, market trends and opportunities, and any further data you may need to thrive in the human acellular dermis industry. This human acellular dermis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human acellular dermis market size has grown strongly in recent years. It will grow from $1.66 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing number of reconstructive surgeries, rising incidence of burn injuries, advancements in tissue processing technologies, growth of cosmetic and plastic surgery procedures, improved donor tissue availability.
The human acellular dermis market size is expected to see strong growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing adoption in regenerative medicine, rising demand for minimally invasive reconstruction solutions, expansion of orthopedic and soft tissue repair applications, growing focus on advanced wound management, increasing innovation in biomaterial processing. Major trends in the forecast period include increasing use of acellular dermal matrices in reconstruction, rising adoption in burn and wound care applications, growing demand for ready-to-use dermal grafts, expansion of plastic and reconstructive surgery procedures, enhanced focus on biocompatibility and integration.
The expansion of plastic surgery procedures is anticipated to drive the growth of the human acellular dermis market in the coming years. Plastic surgery procedures refer to medical interventions that reshape, restore, or enhance the appearance and function of the body through surgical techniques. Plastic surgery procedures are rising due to increasing awareness and demand for aesthetic enhancement, as more individuals seek to improve their appearance and self-confidence through advanced, minimally invasive surgical options. Human acellular dermis (HAD) benefits plastic surgery procedures by acting as a biologically compatible scaffold that integrates with the patient's own tissue, supporting new tissue growth, minimizing scar formation, and enhancing both the aesthetic and functional outcomes of reconstructive or cosmetic surgeries. For example, in June 2024, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization, facial and head aesthetic procedures experienced significant growth compared to the previous year in 2023, totaling over 6.5 million interventions and reflecting a 19.6% rise. Therefore, the expansion of plastic surgery procedures is driving the growth of the human acellular dermis market.
Companies operating in the human acellular dermis market are focusing on developing innovative products, such as thin and porous acellular dermal matrix scaffold technology, to improve handling and conformability to complex wound geometries, enabling easier placement and more consistent clinical outcomes. Thin and porous acellular dermal matrix scaffold technology refers to the engineering of acellular dermal matrices with reduced thickness and interconnected porous structures that enhance cellular infiltration, vascularization, and tissue integration, enabling faster wound healing with fewer clinical applications. For example, in April 2025, LifeNet Health, a US-based regenerative medicine company, introduced Dermacell Porous, an acellular dermal matrix that offers a thin, durable and naturally porous scaffold, enhanced retention of extracellular matrix proteins and cytokines, and easy non-sided application straight from package, facilitating broader clinical adoption for complex wound cases requiring fewer interventions. It is engineered to support chronic wound closure in four or fewer applications and is one of 26 skin substitute grafts and cellular or tissue-based products covered under Medicare's new Local Coverage Determinations effective January 1, 2026. This addition strengthens LifeNet Health's regenerative wound care portfolio and underscores its commitment to delivering advanced and accessible clinical solutions.
In March 2023, Aziyo Biologics Inc., a US-based developer and commercializer of biologic products including human acellular dermal matrices and regenerative biologics, partnered with Sientra Inc. to expand the distribution of Aziyo's SimpliDerm human acellular dermal matrix product line in the United States. This collaboration aims to improve women's access to biologic solutions for soft tissue reconstruction by granting Sientra certain non-exclusive rights to market, sell, and distribute SimpliDerm(R) in reconstructive surgery applications, thereby broadening commercial reach and supporting revenue growth. Sientra Inc. is a US-based medical aesthetics company focused on plastic and reconstructive surgery.
Major companies operating in the human acellular dermis market are Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Integra LifeSciences Corporation, Conmed Corporation, MTF Biologics, MiMedx Group Inc., BioHorizons IPH Inc., LifeNet Health, BioBridge Global, Hans Biomed Corp., PolyNovo Limited, Tissue Regenix Group Plc, CG Bio Inc., Parametrics Medical, Meccellis Biotech, Promethean LifeSciences Inc., Bimini Health Tech LLC, Citagenix Inc., and Aziyo Biologics.
Europe was the largest region in the human acellular dermis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human acellular dermis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the human acellular dermis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The human acellular dermis market consists of sales of acellular dermal matrix sheets, acellular dermal grafts, acellular dermal patches, acellular dermal mesh, acellular dermal scaffolds, acellular dermal membranes, and acellular dermal implants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or processors of the dermis, whether to other entities or directly to institutions. The value of goods in this market includes related services provided by the creators, such as processing, sterilization, and quality assurance.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Acellular Dermis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses human acellular dermis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for human acellular dermis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The human acellular dermis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.